Type I Interferon Receptor Antagonist
- Name
- Type I Interferon Receptor Antagonist
- Accession Number
- DBCAT005528
- Description
Not Available
- Drugs
Drug Drug Description Anifrolumab A monoclonal antibody that inhibits type 1 interferon receptors, indicated in the treatment of moderate to severe systemic lupus erythematosus. - Drugs & Drug Targets
Drug Target Type Anifrolumab Interferon alpha/beta receptor 1 target